rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-6-17
|
pubmed:abstractText |
If erythromycin is micronized into microspheres with suitable particle size, it can improve pulmonary drug concentration to maximize its effectiveness and minimize the adverse side effects. Aim: In this study, erythromycin gelatin microspheres (EM-GMS) were prepared and some characteristics of EM-GMS were investigated. The drug-targeting index (DTI) of EM-GMS was evaluated to predict their potential as a targeted delivery system.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1520-5762
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
639-45
|
pubmed:meshHeading |
pubmed-meshheading:19259878-Animals,
pubmed-meshheading:19259878-Anti-Bacterial Agents,
pubmed-meshheading:19259878-Delayed-Action Preparations,
pubmed-meshheading:19259878-Drug Delivery Systems,
pubmed-meshheading:19259878-Erythromycin,
pubmed-meshheading:19259878-Female,
pubmed-meshheading:19259878-Gelatin,
pubmed-meshheading:19259878-Lung,
pubmed-meshheading:19259878-Male,
pubmed-meshheading:19259878-Mice,
pubmed-meshheading:19259878-Microspheres,
pubmed-meshheading:19259878-Particle Size,
pubmed-meshheading:19259878-Rabbits,
pubmed-meshheading:19259878-Technology, Pharmaceutical,
pubmed-meshheading:19259878-Time Factors,
pubmed-meshheading:19259878-Tissue Distribution
|
pubmed:year |
2009
|
pubmed:articleTitle |
Preparation and characteristics of erythromycin microspheres for lung targeting.
|
pubmed:affiliation |
Department of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, PR China.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|